1. Home
  2. HIMX vs ATAI Comparison

HIMX vs ATAI Comparison

Compare HIMX & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Himax Technologies Inc.

HIMX

Himax Technologies Inc.

HOLD

Current Price

$9.80

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

ATAI

ATAI Life Sciences N.V.

HOLD

Current Price

$3.75

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIMX
ATAI
Founded
2001
2018
Country
Taiwan
United States
Employees
N/A
54
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
HIMX
ATAI
Price
$9.80
$3.75
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$15.57
AVG Volume (30 Days)
2.6M
4.6M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
3.65%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$308,000.00
Revenue This Year
$14.94
N/A
Revenue Next Year
$7.79
$285.00
P/E Ratio
$14.99
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.66
$1.15
52 Week High
$12.00
$6.73

Technical Indicators

Market Signals
Indicator
HIMX
ATAI
Relative Strength Index (RSI) 72.70 46.97
Support Level $8.24 $3.41
Resistance Level N/A $4.40
Average True Range (ATR) 0.57 0.26
MACD 0.30 0.01
Stochastic Oscillator 56.93 31.70

Price Performance

Historical Comparison
HIMX
ATAI

About HIMX Himax Technologies Inc.

Himax Technologies Inc is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The majority of the firm's revenue is derived from the Driver Integrated Circuit segment. It offers display driver ICs and timing controllers used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, virtual reality (VR) devices, and many other consumer electronics devices. It also designs and provides controllers for touch sensor displays, in-cell Touch and Display Driver Integration single-chip solutions, LED driver ICs, power management ICs, and scaler products for monitors and projectors. Geographically, it generates the majority of its revenue from China.

About ATAI ATAI Life Sciences N.V.

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.

Share on Social Networks: